Alaska’s Prescription Drug Monitoring Program (PDMP) is underutilized—only 82 percent of potential prescribers are registered. The Alaska Department of Health and Social Services will use grant funds to assist in assessing the levels of awareness of the PDMP among health-care practitioners; identifying statewide trends in controlled substance prescribing; increasing provider self-awareness of prescribing habits; expanding the data collected by increasing usage of the PDMP; and recommending policy changes to prevent opioid overuse, misuse, abuse, and overdose. The current PDMP program will be enhanced by adding a prescriber report card function to track prescribing habits.
The Alabama Department of Public Health will develop updated training for prescription drug monitoring program (PDMP) users, produce public service announcements to educate the public, integrate the PDMP into electronic health records and pharmacy dispensing software, and analyze the PDMP data.
The Connecticut Prescription Monitoring Program (PMP), in partnership with other state agencies, will merge the Office of the Chief Medical Examiner (OCME) and the state forensic laboratory system with the Connecticut Prescription Monitoring and Reporting System (CPMRS) to allow prescribers and pharmacists to identify patients who have died and reduce inappropriate dispensing; create a new module to allow law enforcement users access to both death data and toxicology information within the CPMRS to assist in their investigations; and conduct educational campaigns to introduce these new features and the benefits that would expand the ability of prescribers, pharmacists, and law enforcement to avoid and deter controlled substance misuse or diversion.
The State of Connecticut Department of Consumer Protection, Drug Control Division is upgrading the Connecticut Prescription Monitoring and Reporting System (CPMRS) to the NarxCare Platform, enhancing the administrator portal features to allow prescription monitoring program (PMP) staff members to better assist all user groups, identify and correct problems, and address requests for research data. The division is adding a Mandatory Use Compliance module to produce PMP administrator reports of providers and review histories, and reports for providers of their missed reviews. It is conducting three educational campaigns to introduce the NarxCare platform, new features, and benefits to prescribers, pharmacists, and law enforcement.
The Florida Department of Health will enhance the Florida Prescription Drug Monitoring Program (PDMP) system, known as E-FORCSE (Electronic-Florida Online Reporting of Controlled Substance Evaluation Program), by employing an epidemiologist to provide data analysis to inform and guide health-care practitioners and policymakers and expanding existing outreach and education. E-FORCSE will also fund integration of PDMP information into clinical workflow by providing mini-grants to small physician practices and independent pharmacies.
Guam’s Department of Public Health and Social Services will enhance and improve data analysis by upgrading to the AWARxE Advanced Prescription Monitoring Program analytics. Guam will also partner with the Commonwealth of the Northern Mariana Islands to increase the capability of public and private pharmacies to report prescription information to the Guam Prescription Drug Monitoring Program (PDMP).
Iowa’s project to enhance the Iowa Prescription Monitoring Program (PMP) is a partnership between the Iowa Department of Public Health (IDPH) Bureau of Substance Abuse and the Iowa Board of Pharmacy, as well as the Governor’s Office of Drug Control Policy. Goals include increasing prescriber registration, increasing access and admission to treatment and recovery support, and implementing multisystem planning and program development. A data analyst position is partially funded through this project; this position serves as a liaison between the state PMP team and other providers and to conduct analysis.
The Idaho Department of Health and Welfare (IDHW) will build a sustainable data infrastructure to ensure timely collection, analysis, and dissemination of opioid data. In addition, an action researcher will establish a suspected drug-induced death mortality review team. The data will be shared with Idaho’s strategic planning workgroup and other stakeholders. To address vulnerable populations, IDHW will work with the Idaho Office of Drug Policy to distribute naloxone in communities across Idaho. To educate prescribers in rural Idaho on substance abuse treatment and safe prescribing, IDHW will work with the University of Idaho to extend its Project ECHO program, an evidence-based, technology-enabled collaborative learning model that builds a clinician’s knowledge and ability to treat complex conditions. To evaluate Idaho’s efforts in educating prescribers on safe prescribing and prescription drug monitoring program (PDMP) utilization, IDHW will contract with a third-party evaluator.
The Idaho State Board of Pharmacy will support the proactive use of the Prescription Drug Monitoring Program (PDMP) by providing practitioners with one-click, in-workflow access to patient information by enhancing Idaho’s Prescription Monitoring Program AWARxE with the NarxCare Enterprise platform and funding implementation fees and Gateway licenses for up to 30 prescribers or dispensers. Idaho will expand the prescriber reports to state-to-state comparison and compare the prescribing habits of a health-care specialty among states. The Board will comply with BJA data sharing requirements by implementing RxCheck.
The Illinois Department of Human Services will, in collaboration with the University of Illinois at Chicago, develop a comprehensive training program that will provide academic detailing, automated connection education, and prescription monitoring program (PMP) website usage education. Working with its vendor, Logicoy, Inc., the grantee will help the Illinois PMP connect to 78 hospital, clinic, or pharmacy electronic health record (EHR) systems, thus reducing the access time from minutes to seconds, which is critical during trauma situations. Finally, in collaboration with the Illinois Department of Public Health, the PMP will expand the unsolicited alert system by increasing the types of alerts sent to hospitals and medical providers.
INSPECT is Indiana’s Prescription Drug Monitoring Program (PDMP) administered by the Indiana Board of Pharmacy. The Indiana Criminal Justice Institute (ICJI) will partner with the Indiana Professional Licensing Agency (IPLA), which oversees INSPECT’s day-to-day operation, and the Indiana Department of Mental Health and Addiction to enhance INSPECT by providing better training resources, better access to INSPECT for some rural dispensers, and production and dissemination of educational materials mainly about new INSPECT integration software. The project will include online tutorials, webinars, improved access for rural pharmacies, and a multimedia campaign to spread awareness. IPLA and INSPECT staff members will gather and report data performance measurements from the INSPECT database.
The Kansas State Board of Pharmacy will improve the existing Kansas Prescription Drug Monitoring Program (PDMP) by adding a prescriber report/score card. The report will show the statistics of a practitioner’s prescribing behavior along with his or her PDMP usage rates. The goal is to improve prescribers’ knowledge of their own practices (historic and current) and provide peer-to-peer comparisons for Kansans prescribing controlled substances, ultimately leading to increased patient care and public safety. Data related to the implementation of the PDMP will be collected and completed by APPRISS Health.
The Kansas Board of Pharmacy, the administrator of the Kansas Prescription Drug Monitoring Program (K-TRACS) will implement a public awareness campaign for K-TRACS; conduct an audit of K-TRACS records and recommend corrective action, remedial measures, and policies; and hire a special investigator to define and develop the criteria to expand the analysis of K-TRACS data by identifying individuals with questionable behaviors, suspicious prescribing patterns, or harmful practices.
St. Tammany Parish will develop an information system to analyze and track the opioid client population across justice system and health intercepts in order to reduce cases of overdose and increase treatment and recovery service access. Key partners for this project include the 22nd Judicial District Court, the Safe Haven Advisory Board, St. Tammany Parish Hospital, the St. Tammany Parish Sheriff’s Office and Jail, and the District Attorney’s Office.
The Massachusetts Department of Public Health will enhance its Prescription Monitoring Program (PMP) to accomplish three goals: (1) develop enhancements to the online Massachusetts Prescription Awareness Tool (MassPAT); (2) improve the quality of prescription information by flagging non- or intermittently reporting pharmacies and by reaching out to pharmacies that have high error submission rates; and (3) analyze and report out on trends in stimulant prescribing. The Department of Public Health will accomplish these goals by evaluating and/or reporting the impact of MassPAT enhancements funded by COAP funding, monitoring the frequency of pharmacies not reporting to the Massachusetts PMP and evaluating the efficacy of pharmacy outreach to correct error submissions, and reporting out on trends on stimulant prescribing.
St. Mary’s County Health Department in Maryland will work with other community agencies to expand the data that are used to support the Opioid Intervention Team. The utilization of Overdose Detection Mapping Application Program (ODMAP), Prescription Drug Monitoring Program (PDMP), and first responder data will be increased. In addition, the agency will increase the multidisciplinary engagements with community organizations and neighboring jurisdictions and increase recovery support services and educational opportunities for prescribers and patients.
The Minnesota Board of Pharmacy will move to the new prescription monitoring program (PMP) AWARxE platform with the inclusion of the deployment of NarxCare analytics, visualizations, and clinical intervention tools. To educate users about the database and the updated functionalities to ensure continued, accurate use of the system, a Quick Tips Guide—which was an appreciated educational tool in the past—will be created and distributed. Finally, the PMP will expand the system’s report-generation capabilities as used by the PMP administrator and the PMP pharmacist consultant to analyze and identify trends and provide requested data to stakeholders.
Missouri is the only state in the United States without a statewide Prescription Drug Monitoring Program (PDMP). With this grant, the St. Louis County PDMP, developed by the St. Louis County Department of Public Health, will become cross-jurisdictional and now includes 72 jurisdictions across Missouri. Project goals include delivering technical assistance and support to promote engagement and use of PDMP information, educating and recruiting additional subscribers to improve the value and utility of the PDMP database, and designing and refining utilization data and reports. A biostatistician was hired in Year One of the project period to establish the data infrastructure for reports and data analysis made possible by the PDMP. The Technical Advisory Committee meets quarterly throughout the project period with the project director.
The Nebraska Department of Health and Human Services Division of Public Health will add provider dashboard enhancements to the Nebraska Prescription Drug Monitoring Program (PDMP) that support clinical decision making. The Division of Public Health will also develop updated training for prescribers, dispensers, and designees on the provider dashboard enhancements and produce updated training videos.
The New Hampshire Prescription Drug Monitoring Program (PDMP) is committed to reducing misuse, abuse, and diversion of prescription controlled substances through the following goals: expand the implementation of information sharing between state PDMPs, improve the quality and accuracy of PDMP data, integrate and examine the effectiveness of PDMP utilization, examine the effectiveness of prescriber- and pharmacist-mandated enrollment of PDMPs, and develop training for practitioners and users of the PDMP. The PDMP will work with members of the Advisory Council to examine through data collection the effectiveness of the prescriber mandate to query the PDMP.
The New Jersey Department of Law and Public Safety will develop clinical alerts and unsolicited reports to alert prescribers of potential doctor/pharmacy shoppers, excessive dosages, and dangerous drug combinations and establish a pharmacy inspection program to audit for prescription drug monitoring program (PDMP) compliance and prompt training and education upon identification of practice deficiencies.
The Nevada State Board of Pharmacy will support the proactive use and enhancement of the Prescription Drug Monitoring Program (PDMP) by (1) enhancing the Nevada PDMP with the addition of NarxCare, a software platform that will improve prescription monitoring program (PMP) reports by allowing for the incorporation of NarxCare analytics, visualizations, clinical intervention tools, and additional public health data sets into Nevada’s PMP AWARxE database; (2) improving the quality and accuracy of PMP data through an extension of the Board of Pharmacy and PMP’s current Audit Project, which looks at the accuracy and completeness of the data in the Nevada PMP; and (3) enhancing the PMP’s ability to provide quality reports of suspected fraudulent or otherwise unlawful or inappropriate prescribing patterns to authorized law enforcement agencies and/or occupational licensing boards for further investigation.
The Reno Police Department, in partnership with the Washoe County Health Department and other community partners, will implement evidence-based practices in the field of tobacco prevention by launching a mass-reach health communication campaign with the goal of changing the social norms surrounding prescribed opioids. This program will also follow up with individuals/families who have experienced a suspected overdose and provide information regarding resources such as how to seek a substance abuse evaluation and/or counseling, medication-assisted treatment (MAT) and other treatment, and where to obtain naloxone. Finally, the program will launch a prescriber education campaign.
The Alcohol, Drug Addiction and Mental Health Services Board of Cuyahoga County will use grant funds to support a Data Subcommittee of the Heroin and Opioid Task Force (HOTF). The Data Subcommittee will develop an action plan and a blueprint for an integrated data sharing platform to be implemented by the HOTF. Begun Center of Case Western Reserve University will serve as the research partner for the proposed project.
The Ohio Board of Pharmacy will improve overall data quality by developing a prescription drug monitoring program (PDMP) enhancement that requires all users to automatically update their information within the system every six months and correct any missing information; create a treatment location tool for clinicians in the Ohio Automated Rx Reporting System (OARRS) that uses dispensing data from the system and other external sources to locate active prescribers of medication-assisted treatment to treat opioid abuse; continue to review data in the state PDMP; and work with state, federal, and local law enforcement to initiate criminal and/or administrative investigations of health-care providers.
The goal of this project is to utilize Ohio’s PDMP to support cross-system collaboration and data sharing among prescribers, law enforcement, and treatment professionals to reduce opioid misuse. Ohio’s PDMP, known as “OARRS,” is operated by the Ohio Board of Pharmacy, which intends to use federal funds to implement the following program enhancements: a new pre-criminal intervention program run by two OARRS intervention agents and a new method that supports clinical decision making by drug court participants to OARRS. To break down silos, the Board plans to collaborate with the Supreme Court of Ohio to report active drug court participants to OARRS.
The Oklahoma Bureau of Narcotics will improve the quality and accuracy of prescription monitoring program (PMP) data by hiring an additional compliance and data quality analyst. The PMP will also add standard reports, more data analytics, and prescriber report cards to reduce inaccurate or missing information and provide users with a complete picture.
The Pennsylvania Department of Health will develop a robust prescriber and dispenser-controlled substance report, strengthen the prescription drug monitoring program (PDMP) system by improving data quality and compliance, produce and disseminate Rx Awareness educational material, and connect to the RxCheck hub to support interstate data sharing.
In accordance with Puerto Rico Bill 70-2017, the Mental Health and Anti-Addiction Services Administration (MHAASA) established the Puerto Rico Prescription Drug Monitoring Program. The PDMP, which started on May 23, 2018, currently has 2,304 users. More than 1,100 pharmacies are entering information into the system at least every 48 hours. The PDMP provides information about dispensed drugs on schedules 2 to 5.
The Rhode Island State Police will implement the Heroin-Opioid Prevention Effort (HOPE) Initiative, the nation’s first statewide law enforcement-led opioid overdose outreach program, modeled after the Police Assisted Addiction and Recovery Initiative (PAARI). The HOPE Initiative engages law enforcement personnel in a proactive outreach strategy to combat the opioid overdose epidemic by bringing together substance-use professionals and members of law enforcement with the mission of reaching out to individuals at risk of overdosing and encouraging them to be assessed and treated. The project will support the technology, professional expertise, and partnerships needed to gather comprehensive data, perform outreach visits, execute research, and contribute to the administration of the HOPE Initiative. Data gathered through the HOPE Initiative will be shared with the Overdose Detection Mapping Application Program (ODMAP). Kelley Research Associates will serve as the project evaluator.
The South Dakota Board of Pharmacy will support the proactive use of the prescription drug monitoring program (PDMP) by providing practitioners with an enhanced patient profile report that will be available via one-click, in-workflow access. Enhancing South Dakota’s prescription monitoring program (PMP) AWARxE with the NarxCare Enterprise platform and facilitating Statewide Gateway Integration will integrate the South Dakota PDMP into all prescriber electronic health record platforms and all pharmacy management systems.
The Tennessee Department of Health will improve the state prescription drug monitoring program (PDMP) (known as the Controlled Substances Monitoring Database [CSMD]) by joining the RxCheck hub, exploring the potential for integrating into electronic health records in Tennessee, and incorporating additional risk models and clinical information that can provide enhanced data to sites engaged in electronic health record integration.
The Utah Department of Health Violence and Injury Prevention Program will improve the quality and accuracy of Utah’s prescription drug monitoring program (PDMP), known as the Controlled Substance Database, by developing a data quality assurance program, developing the infrastructure for users and system audit logging, and improving Controlled Substance Database (CSD) infrastructure and reports.
The Washington Department of Health will hire a prescription drug monitoring program (PDMP) onboarding coordinator (management analyst) who will perform outreach and education, and provide onboarding assistance to facilities interested in integrating the PDMP query into their electronic health record (EHR) systems. Washington’s Emergency Department Information Exchange (EDIE) is a care management tool that has been largely successful in integrating PDMP data into its reports. By supporting more EHR-PDMP integration, it is expected that more health-care organizations will uptake the technology and fully adopt the Agency Medical Directors Group (AMDG) Interagency Guideline for Prescribing Opioids for Pain. The Prescription Monitoring Program at the Washington State Department of Health will work with stakeholders, other state agencies, and health-care providers to develop metrics and measures to be included in provider feedback reports sent to prescribers to inform them of their own prescribing practices and how their practices relate to other prescribers of similar licensure and specialty.
The Washington State Department of Health (DOH) will engage a competitive solicitation through a Request for Proposal (RFP) process for a vendor-provided Prescription Drug Monitoring Program (PDMP) solution and contract with the winning vendor. Specific breakdown of costs for system enhancement, customization, and implementation will be provided by prospective vendors via the RFP process. To develop a Request for Proposal, Washington PMP will engage in an evaluation project with DOH IT resources to evaluate the needs of the program, enterprise needs of the agency, and options for PMP system replacement. Awarded funds will be used to support the staff and resources in developing the Request for Proposal announcement, including review of program needs and alignment with agency enterprise needs.
The Wisconsin Department of Safety and Professional Services will enhance interoperability for health-care professional users of the Wisconsin Prescription Drug Monitoring Program (WI ePDMP) by adding interstate data and electronic health record (EHR) integration options. This will be achieved by connecting to the RxCheck hub and developing specifications for an alternate EHR integration option for smaller clinical practices.
The Wisconsin Department of Safety and Professional Services will enhance the Wisconsin Prescription Drug Monitoring Program (WI ePDMP) by convening user groups to identify and prioritize future enhancements to the WI ePDMP system. The Wisconsin Department of Safety and Professional Services will work to develop and deploy enhancements to meet user needs for a clinical decision support tool, a prescribing practice assessment tool, an interdisciplinary communication tool, and a public health tool.